8-K Spyre Therapeutics, Inc. 2026-09-08: filed_by
| Value | {"cik": "0001636282", "company": "Spyre Therapeutics, Inc.", "accession": "0001636282-26-000113", "entity_ref": "609146c9-9320-4555-9ba7-d08110a71bcc", "period_of_report": "2026-09-08"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K Spyre Therapeutics, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000113/0001636282-26-000113-in
Retrieved: 2026-09-08T14:17:34.842910+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/7698c9d9-da1f-47a3-b037-2c7ef90eef1d
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000113/0001636282-26-000113-in
Retrieved: 2026-09-08T14:17:34.842910+02:00
Raw response sha256:
d6d05d9478ed73e2ce856581fb84e8cc…Cite as: FACTANKER, https://factanker.com/fact/7698c9d9-da1f-47a3-b037-2c7ef90eef1d
History
- no predecessors — first report